Prognostic Evaluation of CapG, Gelsolin, P-gp, GSTP1, and Topo-II Proteins in Non-Small Cell Lung Cancer

Anatomical Record

Volumn 295, Issue 2, 2012, Pages 208-214

  Zhu, Wang Yu ^a   Hunag, Yan Yan ^a   Liu, Xiao Guang ^a   He, Jian Ying ^a   Chen, Dong Dong ^a   Zeng, Fang ^a   Zhou, Ji Hang ^a   Zhang, Yong Kui ^b  

^a Zhoushan Hospital BIG/CAS   (China)

^b Zhoushan Hospital   (China)

Author keywords

CapG; Gelsolin; NSCLC; P gp; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CAPG PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); GELSOLIN; GLUTATHIONE TRANSFERASE P1; PERMEABILITY GLYCOPROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; FEMALE; GELSOLIN; GLUTATHIONE S-TRANSFERASE PI; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NUCLEAR PROTEINS; P-GLYCOPROTEIN; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84855769823     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21523     Document Type: Article

References (23)

1. Chellaiah M, Kizer N, Silva M, Alvarez U, Kwiatkowski D, Hruska KA. 2000. Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J Cell Biol 148: 665-678.
2. Dahl E, Sadr-Nabavi A, Klopocki E, Betz B, Grube S, Kreutzfeld R, Himmelfarb M, An HX, Gelling S, Klaman I, Hinzmann B, Kristiansen G, Grützmann R, Kuner R, Petschke B, Rhiem K, Wiechen K, Sers C, Wiestler O, Schneider A, Höfler H, Nährig J, Dietel M, Schäfer R, Rosenthal A, Schmutzler R, Dürst M, Meindl A, Niederacher D. 2005. Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer. J Pathol 205: 21-28.
3. Dosaka-Akita H, Hommura F, Fujita H, Kinoshita I, Nishi M, Morikawa T, Katoh H, Kawakami Y, Kuzumaki N. 1998. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res 58: 322-327.
4. Giaccone G. 1994. DNA topoisomerases and topoisomerase inhibitors. Pathol Biol 42: 346-352.
5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. 2009. Cancer statistics (2009). CA Cancer J Clin 59: 225-249.
6. Kang S, Kim MJ, An H, Kim BG, Choi YP, Kang KS, Gao MQ, Park H, Na HJ, Kim HK, Yun HR, Kim DS, Cho NH. 2010. Proteomic molecular portrait of interface zone in breast cancer. J Proteome Res 9: 5638-5645.
7. Lee HK, Driscoll D, Asch H, Asch B, Zhang PJ. 1999. Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate. Prostate 40: 14-19.
8. Liao CJ, Wu TI, Huang YH, Chang TC, Wang CS, Tsai MM, Hsu CY, Tsai MH, Lai CH, Lin KH. 2011. Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance. Gynecol Oncol 120: 135-144.
9. Nomura H, Uzawa K, Ishigami T, Kouzu Y, Koike H, Ogawara K, Siiba M, Bukawa H, Yokoe H, Kubosawa H, Tanzawa H. 2008. Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity. BMC Cancer 8: 39.
10. Onoda K, Yu FX, Yin HL. 1993. gCap39 is a nuclear and cytoplasmic protein. Cell Motil Cytoskeleton 26: 227-238.
11. Partheen K, Levan K, Osterberg L, Claesson I, Fallenius G, Sundfeldt K, Horvath G. 2008. Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. Int J Cancer 123: 2130-2137.
12. Renz M, Langowski J. 2008. Dynamics of the CapG actin-binding protein in the cell nucleus studied by FRAP and FCS. Chromosome Res 16: 427-437.
13. Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K. 2008. Expression of multidrug resistance-related proteins p-Glycoproteing lutathione rase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Cancer Investig 26: 344-351.
14. Tanaka M, Müllauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N. 1995. Gelsolin: a candidate for suppressor of human bladder cancer. Cancer Res 55:3228-3232.
15. Tanaka PY, Calore EE. 2007. P-glycoprotein expression in non-Hodgkin's lymphomas of human immunodeficiency virus infected patients. Pathol Res Pract 203: 1-7.
16. Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, Prime W, Campbell F, Dodson A, Jenkins RE, Lemoine NR, Crnogorac-Jurcevic T, Yin HL, Costello E. 2007. Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut 56: 95-106.
17. Thor AD, Edgerton SM, Liu S, Moore DH, Kwiatkowski DJ. 2001. Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers. Clin Cancer Res 7: 2415-2424.
18. Triller N, Korosec P, Kern I, Kosnik M, Debeljak A. 2006. A multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease. Lung Cancer 54: 235-240.
19. Van den Abbeele A, De Corte V, Van Impe K, Bruyneel E, Boucherie C, Bracke M, Vandekerckhove J, Gettemans J. 2007. Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro. Cancer Lett 255: 57-70.
20. Van Ginkel PR, Gee RL, Walker TM, Hu DN, Heizmann CW, Polans AS. 1998. The identification and differential expression of calcium-binding proteins associated with ocular melanoma. Biochim Biophys Acta 1448: 290-297.
21. Veerle DC, Katrien VI, Erik B, Ciska B, Marc M, Joël Vand Jan G. 2004. Increased importin-b-dependent nuclear import of the actin modulating protein CapG promotes cell invasion. J Cell Sci 117: 5283-5292.
22. Xu SG, Yan PJ, Shao ZM. 2010. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis. J Cancer Res Clin Oncol 136: 1545-1556.
23. Yang J, Tan D, Asch HL, Swede H, Bepler G, Geradts J, Moysich KB. 2004. Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer. Lung Cancer 46: 29-42.